SCHEMBL21717832

SCHEMBL21717832

c1ccc(-c2cccc(-c3ccc4c(c3)c3c5ccccc5cc5c6ccccc6n4c53)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 4/20 0.39
KDM4E B2RXH2 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HTR6 P50406 2/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
PTGES O14684 1/20 0.33
NPY5R Q15761 1/20 0.32
MAOB P27338 1/20 0.32
NR3C1 P04150 1/20 0.32
PLA2G10 O15496 1/20 0.32
PLA2G2A P14555 1/20 0.32
PLA2G4A P47712 1/20 0.32
LDHA P00338 1/20 0.32
HSD17B1 P14061 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22679275 0.97 TSPO (0.39) TSPOKDM4ETSHRHSD17B10HTR6
SCHEMBL22858283 0.97 TSPO (0.40) TSPOKDM4ETSHRHSD17B10HTR6
SCHEMBL21717382 0.97 TSPO (0.40) TSPOKDM4ETSHRHSD17B10HTR6
SCHEMBL21718109 0.94 TSPO (0.36) TSPOKDM4ETSHRHSD17B10HTR6
SCHEMBL25965152 0.92 TSPO (0.38) TSPOKDM4ETSHRHSD17B10HTR6
SCHEMBL21718108 0.92 TSPO (0.36) TSPOKDM4ETSHRHSD17B10HTR6
SCHEMBL21717841 0.92 TSPO (0.38) TSPOKDM4ETSHRHSD17B10HTR6
SCHEMBL21717407 0.92 TSPO (0.38) TSPOKDM4ETSHRHSD17B10HTR6
SCHEMBL22858284 0.89 ESR1 (0.38) TSPOKDM4ETSHRHSD17B10HTR6
SCHEMBL21717831 0.89 TSPO (0.33) TSPOKDM4ETSHRHSD17B10PSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE LEF1, L1CAM, ESR2 TSPO 1263/4885KDM4E 2210/4885TSHR 4428/4885
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE OR51E2, CD99, CTNND1 TSPO 1545/4885KDM4E 2086/4885TSHR 4112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.